NCT04810351

Brief Summary

Objective: Fever of unknown (FUO) origin remains challenging in geriatric patients. Geriatric patients have a blunted immune response responsible for altered fever mechanisms and immune cells responses. Consequently, FUO could be inappropriately named and could be changed in Inflammation of unknown origin (IUO) in this specific population. Furthermore, the studies of FUO in this group are (out)dated and the diagnostic methods have evolved achieving a better sensitivity and specificity. The aim of our study is to assess the spectrum of diseases responsible of FUO or IUO in elderly patients compared to younger patients and to define the diagnostic approach using new diagnostic investigations. The second aim of our study is to assess the usefulness of inflammatory markers, demographic data and comorbidity to differentiate the cause of FUO/IUO. Design: Patients with FUO or IUO will prospectively be recruited at the geriatric unit and the internal medicine unit of the UZ hospital during four years. The demographic, social and medical data will be screened. All diagnostic methods will be described.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 22, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

2.2 years

First QC Date

March 11, 2021

Last Update Submit

April 28, 2026

Conditions

Keywords

FUOFever of unknown origin

Outcome Measures

Primary Outcomes (3)

  • the spectrum of diseases responsible of FUO or IUO

    The proportion of infectious diseases, of neoplasm, of multi system disease of pulmonary embolism or deep vein thrombosis, of intoxication door medication will be measured in both groups

    through study completion, an average of 1 year

  • definition of FUO

    we would like to compare fever of unknown origin since three weeks with fever of unknown origin since one week

    through study completion, an average of 1 year

  • Diagnostic approach of FUO

    To describe the diagnostic approach and compare these diagnostic test in young and old population.

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Factors which influence FUO

    At baseline

Study Arms (4)

Younger 1

young patients ( 18-69 years old) with oral or rectal fever \> 37°8 or tympanic fever \> 37°2 or CRP \> 30 mg/dl during more than one week but less than three weeks of hospital with appropriate intelligent standard inpatient or outpatient workup to rule out usual causes of fever

Other: observational study

Older 1

old patients ( \> 70 years old) with oral or rectal fever \> 37°8 or tympanic fever \> 37°2 or CRP \> 30 mg/dl during more than one week but less than three weeks out of hospital with appropriate intelligent standard inpatient or outpatient workup to rule out usual causes of fever

Other: observational study

Young 2

young patients (18-69 years old) with oral or rectal fever \> 37°8 or tympanic fever \> 37°2 or CRP \> 30 mg/dl during more than 3 weeks with appropriate intelligent standard inpatient or outpatient workup to rule out usual causes of fever.

Other: observational study

Older 2

old patients ( \> 70 years old) with oral or rectal fever fever \> 37°8 or tympanic fever \> 37°2 or CRP \> 30 mg/dl during 3 weeks with appropriate intelligent standard inpatient or outpatient workup to rule out usual causes of fever13 .

Other: observational study

Interventions

There is no intervention. It is an observational study

Older 1Older 2Young 2Younger 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be recruited at the geriatric unit and internal medicine unit or geriatric outpatient clinic of UZ Brussel and will be followed during one year. Cfr inclusion and exclusion criteria

You may qualify if:

  • fever during more than one week out of hospital or more than 3 weeks with an intelligent appropriate workup
  • an inflammatory syndrome during more than one week out of hospital or more than 3 weeks out of hospital

You may not qualify if:

  • no inform consent
  • Age \< 18 years old
  • Neutropenia, HIV or nosocomial fever of unknown origins are excluded. Immunodepressed patients are also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ brussel

Brussels, Jette, 1090, Belgium

Location

Related Publications (12)

  • Norman DC. Fever in the elderly. Clin Infect Dis. 2000 Jul;31(1):148-51. doi: 10.1086/313896. Epub 2000 Jul 25.

    PMID: 10913413BACKGROUND
  • Norman DC, Yoshikawa TT. Fever in the elderly. Infect Dis Clin North Am. 1996 Mar;10(1):93-9. doi: 10.1016/s0891-5520(05)70288-9.

    PMID: 8698997BACKGROUND
  • Tal S, Guller V, Gurevich A. Fever of unknown origin in older adults. Clin Geriatr Med. 2007 Aug;23(3):649-68, viii. doi: 10.1016/j.cger.2007.03.004.

    PMID: 17631239BACKGROUND
  • Tal S, Guller V, Gurevich A, Levi S. Fever of unknown origin in the elderly. J Intern Med. 2002 Oct;252(4):295-304. doi: 10.1046/j.1365-2796.2002.01042.x.

    PMID: 12366602BACKGROUND
  • Norman DC, Wong MB, Yoshikawa TT. Fever of unknown origin in older persons. Infect Dis Clin North Am. 2007 Dec;21(4):937-45, viii. doi: 10.1016/j.idc.2007.09.003.

    PMID: 18061083BACKGROUND
  • Vanderschueren S, Del Biondo E, Ruttens D, Van Boxelaer I, Wauters E, Knockaert DD. Inflammation of unknown origin versus fever of unknown origin: two of a kind. Eur J Intern Med. 2009 Jul;20(4):415-8. doi: 10.1016/j.ejim.2009.01.002. Epub 2009 Feb 1.

    PMID: 19524186BACKGROUND
  • Knockaert DC, Vanneste LJ, Bobbaers HJ. Fever of unknown origin in elderly patients. J Am Geriatr Soc. 1993 Nov;41(11):1187-92. doi: 10.1111/j.1532-5415.1993.tb07301.x.

    PMID: 8227892BACKGROUND
  • Woolery WA, Franco FR. Fever of unknown origin: keys to determining the etiology in older patients. Geriatrics. 2004 Oct;59(10):41-5.

    PMID: 15508555BACKGROUND
  • Gafter-Gvili A, Raibman S, Grossman A, Avni T, Paul M, Leibovici L, Tadmor B, Groshar D, Bernstine H. [18F]FDG-PET/CT for the diagnosis of patients with fever of unknown origin. QJM. 2015 Apr;108(4):289-98. doi: 10.1093/qjmed/hcu193. Epub 2014 Sep 9.

    PMID: 25208896BACKGROUND
  • Schonau V, Vogel K, Englbrecht M, Wacker J, Schmidt D, Manger B, Kuwert T, Schett G. The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2018 Jan;77(1):70-77. doi: 10.1136/annrheumdis-2017-211687. Epub 2017 Sep 19.

    PMID: 28928271BACKGROUND
  • Mardi D, Fwity B, Lobmann R, Ambrosch A. Mean cell volume of neutrophils and monocytes compared with C-reactive protein, interleukin-6 and white blood cell count for prediction of sepsis and nonsystemic bacterial infections. Int J Lab Hematol. 2010 Aug 1;32(4):410-8. doi: 10.1111/j.1751-553X.2009.01202.x. Epub 2009 Nov 16.

    PMID: 19919621BACKGROUND
  • Fusco FM, Pisapia R, Nardiello S, Cicala SD, Gaeta GB, Brancaccio G. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005-2015 systematic review. BMC Infect Dis. 2019 Jul 22;19(1):653. doi: 10.1186/s12879-019-4285-8.

    PMID: 31331269BACKGROUND

MeSH Terms

Conditions

Fever of Unknown Origin

Interventions

Observation

Condition Hierarchy (Ancestors)

FeverBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Nathalie Compte, MD, PhD

    Universitair Ziekenhuis Brussel

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinic head of geriatric unit

Study Record Dates

First Submitted

March 11, 2021

First Posted

March 22, 2021

Study Start

October 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

No plan

Locations